Author:
Bai Jane PF,Wang Jie,Zhang Yifei,Wang Lingshan,Jiang Xiling
Reference57 articles.
1. National Center for Advancing Translational Science, National Institute of Health. Accessed October 2022. Genetic and Rare Diseases Information Center. https://rarediseases.info.nih.gov/about.
2. US Food and Drug Administration. Accessed October 2022. Rare Diseases at FDA. https://www.fda.gov/patients/rare-diseases-fda.
3. Translational quantitative systems pharmacology in drug development: from current landscape to good practices;Bai;AAPS J,2019
4. Quantitative systems pharmacology: landscape analysis of regulatory submissions to the US Food and Drug Administration;Bai;CPT Pharmacometrics Syst Pharmacol,2021
5. Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis;Schmidt;BMC Bioinformatics,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献